loading...| Preferred Name |
Resveratrol |
|
| Synonyms |
Resveratrol resveratrol RESVERATROL 3,4',5-Stilbenetriol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol |
|
| Definitions |
A phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner. (NCI05) |
|
| ID |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C1215 |
|
| ALT_DEFINITION |
A substance found in the skins of grapes and in certain other plants, fruits, and seeds. It is made by various plants to help defend against invading fungi, stress, injury, infection, and too much sunlight. It is being studied in the prevention of cancer and heart disease. It is a type of antioxidant and a type of polyphenol. |
|
| CAS_Registry |
501-36-0 |
|
| CHEBI_ID |
CHEBI:27881 CHEBI:45713 |
|
| Chemical_Formula |
C14H12O3 |
|
| code |
C1215 |
|
| Concept_In_Subset |
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C176424 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157711 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173381 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C157712 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C173383 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116978 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C142799 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C116977 http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl#C128784 |
|
| Contributing_Source |
CTRP FDA GDC |
|
| DEFINITION |
A phytoalexin derived from grapes and other food products with antioxidant and potential chemopreventive activities. Resveratrol induces phase II drug-metabolizing enzymes (anti-initiation activity); mediates anti-inflammatory effects and inhibits cyclooxygenase and hydroperoxidase functions (anti-promotion activity); and induces promyelocytic leukemia cell differentiation (anti-progression activity), thereby exhibiting activities in three major steps of carcinogenesis. This agent may inhibit TNF-induced activation of NF-kappaB in a dose- and time-dependent manner. (NCI05) |
|
| Display_Name |
Resveratrol |
|
| FDA_UNII_Code |
Q369O8926L |
|
| FULL_SYN |
Resveratrol resveratrol RESVERATROL 3,4',5-Stilbenetriol (E)-5-[2-(4-Hydroxyphenyl)ethenyl]-1,3-benzenediol |
|
| Is_Value_For_GDC_Property | ||
| label |
Resveratrol |
|
| Legacy Concept Name |
Resveratrol |
|
| Maps_To |
Resveratrol |
|
| NCI_Drug_Dictionary_ID |
405819 |
|
| NSC Number |
327430 |
|
| PDQ_Closed_Trial_Search_ID |
405819 |
|
| PDQ_Open_Trial_Search_ID |
405819 |
|
| Preferred_Name |
Resveratrol |
|
| prefixIRI |
Thesaurus:C1215 |
|
| Semantic_Type |
Organic Chemical Pharmacologic Substance |
|
| UMLS_CUI |
C0073096 |
|
| subClassOf |